MYGN: Nilai perusahaan marang bathi resik Myriad Genetics Inc

Optimizing IT infrastructure through cloud partners while maintaining an internal R&D center stabilizes the efficiency of Myriad Genetics, Inc. (MYGN). The company's monthly P/E dynamics confirm this resilience, and -4.20 captures the current state of the parameter. Growth is driven by patents and leadership in psychiatric testing, while high-precision laboratories in the US guarantee the accuracy of personalized diagnostics.

Myriad Genetics Inc (MYGN): Rasio rega marang bathi saka 04.07.2022 nganti 14.11.2026

Rincian analitis perusahaan Myriad Genetics, Inc.

- rega saham lan prakiraan rega para ahli:

Bagan owah-owahan rega myriad.com|MYGN - Target konsensus

- informasi kapitalisasi pasar:

Nilai pasar Myriad Genetics, Inc.|MYGN - Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Nilai Buku saben Saham Myriad Genetics|MYGN - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku myriad.com|MYGN - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Total Utang marang Modal Myriad Genetics, Inc.|MYGN - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Myriad|MYGN - Gunggung utang perusahaan|Utang-utang marang nilai buku Myriad Genetics, Inc.|MYGN - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Myriad Genetics|Koefisien jangkoan perantara myriad.com

- data bathi resik lan rasio valuasi:

MYGN - Bathi resik perusahaan|Prakiraan bathi perusahaan Myriad Genetics, Inc.|MYGN - Rasio rega marang bathi|Prakiraan rega marang bathi Myriad Genetics Inc|MYGN - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Myriad Genetics, Inc.|MYGN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Myriad Genetics|MYGN - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan myriad.com|MYGN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Myriad Genetics, Inc.

- indikator volume dodolan lan pendapatan:

MYGN - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan myriad.com|MYGN - Kapitalisasi marang pendapatan|Rega forward marang dodolan Myriad Genetics, Inc.

Analisis umum perusahaan:MYGN (myriad.com)

For Myriad Genetics, Inc. (MYGN), a molecular diagnostics pioneer with a unique array of genetic patents, the price-to-earnings ratio serves as a gauge of market expectations. By analyzing the P/E ratio, an investor determines the number of years required for capital recovery through current earnings, which allows for a comparison of GeneSight therapy's value against the actual monetization rates of intellectual capital and the resilience of the business model.

Analisis perusahaan pesaing